Related Experiment Videos
Triple Starr valve replacement
Insights
Triple valve replacement offers a promising long-term outlook for patients with rheumatic triple valve disease. Most patients lead normal lives post-surgery, suggesting it may be superior to cardiac transplantation.
Area of Science:
- Cardiovascular Surgery
- Cardiac Valve Disease
- Rheumatic Heart Disease
Background:
- Rheumatic heart disease frequently affects multiple heart valves.
- Surgical intervention is often necessary for severe triple valve disease.
- Previous studies explored cardiac transplantation as a treatment option.
Purpose of the Study:
- To evaluate the long-term outcomes of triple valve replacement in patients with rheumatic heart disease.
- To compare the efficacy of triple valve replacement with cardiac transplantation.
Main Methods:
- Retrospective analysis of nine patients undergoing triple valve replacement.
- Assessment of postoperative mortality and long-term patient survival.
- Clinical follow-up to determine functional status and quality of life.
Main Results:
- Three out of nine patients experienced mortality within the study period.
- Postoperative deaths were attributed to myocardial reserve and cerebral embolism.
- The majority of surviving patients demonstrated good recovery and led normal lives.
Conclusions:
- Triple valve replacement is a viable treatment for rheumatic triple valve disease.
- Long-term outcomes suggest potential advantages over cardiac transplantation.
- Further research is warranted to confirm these findings and optimize patient selection.
Abstract:
Of nine patients who have had triple valve replacements for organic rheumatic triple valve disease two died in the postoperative period from inadequate myocardial reserve, and a third died four months later from cerebral embolism originating from clot on the left atrial wall. The remainder are well and, except for one, leading normal lives. Though cardiac transplantation has been recommended and used successfully for triple valve disease by Cooley, it is suggested that the long-term outlook today of triple valve replacement is likely to be better than that of transplantation.